Endo International plc announced that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping the first generic version of Merz’s CUVPOSA® 1 mg/5 mL oral solution in the U.S., following final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application.
January 4, 2022
· 4 min read